Verónica White1, Alicia Jawerbaum1, María B Mazzucco1, Martin Gauster2, Gernot Desoye3, Ursula Hiden3. 1. Laboratory of Reproduction and Metabolism, Center for Pharmacological and Botanical Studies, CEFyBO-CONICET, School of Medicine, University of Buenos Aires, Buenos Aires, Argentina. 2. Institute of Cell Biology, Histology and Embryology, Medical University of Graz, Graz, Austria. 3. Department of Obstetrics and Gynaecology, Medical University of Graz, Graz, Austria.
Abstract
BACKGROUND: Diabetes in pregnancy affects fetal growth and development. The insulin/insulin-like growth factors (IGF) system comprising insulin, IGF, their receptors, and binding proteins, has been implicated in fetal growth regulation. This study tested the hypothesis that maternal diabetes alters the fetal insulin/IGF system in a tissue-specific manner. METHODS: Wistar rats were rendered diabetic by neonatal administration of streptozotocin and mated with control rats. At day 21 of gestation, the weights of fetuses, placentas, and fetal organs (heart, lung, liver, stomach, intestine, and pancreas) were determined. Maternal and fetal plasma concentrations of insulin, IGF1, and IGF2 were measured by ELISA, and expression of IGF1, IGF2, IGF1R, IGF2R, IR, IGFBP1, BP2, and BP3 in placenta and fetal organs by qPCR. RESULTS: The well-known increase in fetal growth in this model of mild diabetes is accompanied by elevated insulin and IGF1 levels and alterations of the insulin/IGF system in the fetus and the placenta. These alterations were organ and gene specific. The insulin/IGF system was generally upregulated, especially in the fetal heart, while it was downregulated in fetal lung. CONCLUSION: In our model of mild diabetes, the effect of maternal diabetes on fetal weight and fetal insulin/IGF system expression is organ specific with highly sensitive organs such as lung and heart, and organs that were less affected, such as stomach.
BACKGROUND:Diabetes in pregnancy affects fetal growth and development. The insulin/insulin-like growth factors (IGF) system comprising insulin, IGF, their receptors, and binding proteins, has been implicated in fetal growth regulation. This study tested the hypothesis that maternal diabetes alters the fetal insulin/IGF system in a tissue-specific manner. METHODS:Wistar rats were rendered diabetic by neonatal administration of streptozotocin and mated with control rats. At day 21 of gestation, the weights of fetuses, placentas, and fetal organs (heart, lung, liver, stomach, intestine, and pancreas) were determined. Maternal and fetal plasma concentrations of insulin, IGF1, and IGF2 were measured by ELISA, and expression of IGF1, IGF2, IGF1R, IGF2R, IR, IGFBP1, BP2, and BP3 in placenta and fetal organs by qPCR. RESULTS: The well-known increase in fetal growth in this model of mild diabetes is accompanied by elevated insulin and IGF1 levels and alterations of the insulin/IGF system in the fetus and the placenta. These alterations were organ and gene specific. The insulin/IGF system was generally upregulated, especially in the fetal heart, while it was downregulated in fetal lung. CONCLUSION: In our model of mild diabetes, the effect of maternal diabetes on fetal weight and fetal insulin/IGF system expression is organ specific with highly sensitive organs such as lung and heart, and organs that were less affected, such as stomach.
Authors: Victor Do; Luke Eckersley; Lily Lin; Sandra T Davidge; Michael K Stickland; Tiina Ojala; Jesus Serrano-Lomelin; Lisa K Hornberger Journal: CJC Open Date: 2020-11-13
Authors: Alberto Roselló-Díez; Linda Madisen; Sébastien Bastide; Hongkui Zeng; Alexandra L Joyner Journal: PLoS Biol Date: 2018-06-26 Impact factor: 8.029
Authors: Udo R Markert; Telma M T Zorn; Rodolfo R Favaro; Diana M Morales-Prieto; Jörg Herrmann; Jürgen Sonnemann; Ekkehard Schleussner Journal: Arch Gynecol Obstet Date: 2021-02-11 Impact factor: 2.344